131 related articles for article (PubMed ID: 4723957)
1. Serum levels of copper, caeruloplasmin and caeruloplasmin oxidase activity in women using copper-containing intrauterine devices and in women taking combined oral contraceptives.
Daunter B; Elstein M
J Obstet Gynaecol Br Commonw; 1973 Jul; 80(7):644-7. PubMed ID: 4723957
[No Abstract] [Full Text] [Related]
2. Raised serum copper and caeruloplasmin levels in subjects taking oral contraceptives.
Carruthers ME; Hobbs CB; Warren RL
J Clin Pathol; 1966 Sep; 19(5):498-500. PubMed ID: 5919365
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives and copper metabolism.
Briggs M; Austin J; Staniford M
Nature; 1970 Jan; 225(5227):81. PubMed ID: 5410207
[No Abstract] [Full Text] [Related]
4. Volume and copper concentration of menstrual discharge from women employing copper-7 and other types of contraceptives.
Laufe LE; Gibor Y; McClanahan BJ; Wheeler RF
Adv Plan Parent; 1974; 9():38-42. PubMed ID: 4468904
[No Abstract] [Full Text] [Related]
5. Serum copper and zinc in hormonal contraceptive users.
Prema K; Ramalakshmi BA; Babu S
Fertil Steril; 1980 Mar; 33(3):267-71. PubMed ID: 6444895
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral contraceptive agents on copper and zinc balance in young women.
Crews MG; Taper LJ; Ritchey SJ
Am J Clin Nutr; 1980 Sep; 33(9):1940-5. PubMed ID: 7416062
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
8. Copper absorption from I.U.C.D.s.
Elstein M; Daunter B
Br Med J; 1973 Jun; 2(5869):776. PubMed ID: 4718330
[No Abstract] [Full Text] [Related]
9. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
10. Significance of plasma copper and caeruloplasmin concentrations in rheumatoid arthritis.
Bajpayee DP
Ann Rheum Dis; 1975 Apr; 34(2):162-5. PubMed ID: 49178
[TBL] [Abstract][Full Text] [Related]
11. Hypercupremia secondary to oral contraceptives: report of 2 cases.
Araujo Castro M; Prieto Coca L; Izquierdo Álvarez C; Oliván Palacios B; Campos Del Portillo R
Endocrinol Diabetes Nutr; 2017 Nov; 64(9):509-511. PubMed ID: 29050708
[No Abstract] [Full Text] [Related]
12. [The behaviour of serum-coeruplasmin in women with intrauterine pessary containing copper (author's transl)].
Tatra G; Beck A; Nikorovicz F
Geburtshilfe Frauenheilkd; 1979 Jun; 39(6):487-91. PubMed ID: 478261
[TBL] [Abstract][Full Text] [Related]
13. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
14. [Serum copper oxidase and ceruloplasmin in hepatic coma].
Ventura E; Zeneroli ML; Marani L; Calandra S
Arch Ital Mal Appar Dig; 1967; 34(6):606-11. PubMed ID: 5606030
[No Abstract] [Full Text] [Related]
15. Variations in serum copper and ceruloplasmin activity following a long term intake of combined oral contraceptives in Iranian women.
Kamyab S; Baghdiantz A; Jenati S
J Endocrinol Invest; 1980; 3(2):173-5. PubMed ID: 7391523
[TBL] [Abstract][Full Text] [Related]
16. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
17. Caeruloplasmin and green plasma in women taking oral contraceptives, in pregnant women, and in patients with rheumatoid arthritis.
Tovey LA; Lathe GH
Lancet; 1968 Sep; 2(7568):596-600. PubMed ID: 4175158
[No Abstract] [Full Text] [Related]
18. Copper:caeruloplasmin ratio.
Twomey PJ; Viljoen A; House IM; Reynolds TM; Wierzbicki AS
J Clin Pathol; 2007 Apr; 60(4):441-2. PubMed ID: 17405985
[TBL] [Abstract][Full Text] [Related]
19. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of three oral contraceptives: comparison of bleeding patterns by contraceptive types and steroid levels.
Saleh WA; Burkman RT; Zacur HA; Kimball AW; Kwiterovich P; Bell WK
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1740-5; discussion 1745-7. PubMed ID: 8317516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
